COVID-19 (Coronavirus) Update

As the level of COVID-19 infections begins to stabilize in our community, we are starting to reschedule appointments, surgeries, and procedures that were delayed during the pandemic. Learn more about how Duke Health is committed to keeping you safe. Visitor restrictions remain in effect. 

Home Clinical Trials at Duke Clinical Trials Directory

B cells in Adult and Children with Lupus - Clinical Trial

What is the Purpose of this Study?

We are doing this study to better understand what causes lupus and how lupus is different in children versus adults.
What is the Condition Being Studied?
Systemic Lupus Erythematosus (Lupus, or SLE)

Who Can Participate in the Study?

To join this study, you must:
- Be 11-18 or 26-50 years old
- Have been diagnosed with SLE (Lupus) in the past 10 years
- Have not been treated with rituximab or cyclophosphamide in the past 2 years
- Have not been treated with belimumab in the past 6 months
- Not have an active infection
- Not have another rheumatologic diagnosis

Age Group
Adults, Children

What is Involved?

If you agree to join this study, you will have only one study visit for a blood test.

Study Details

Full Title
Comparing B Cell Tolerance Checkpoints Between Pediatric-Onset and Adult-Onset Lupus
Principal Investigator
Protocol Number
IRB: PRO00080281
Learn More About Clinical Trials at Duke
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698